TABLE 7.
Country | Sequence Type (ST) (n) | spa types (n) | MRSA n (%) | PVL n (%) |
Burkina Faso (N = 3)* | ST152 (3) | t314 (1), t355 (1), t4198 (1) | 0(0) | 3 (100) |
Gabon (N = 3)* | ST152 (2), ST8 (1) | t355 (2), t1476 (1) | 0(0) | 2 (67) |
Ghana (N = 5)* | ST121 (1), ST152 (1), ST15 (1), ST88 (2) | t314 (1), t4454 (1), t355 (1), t186 (2) | 2(40) | 3 (60) |
Tanzania (N = 5)* | ST 152(4), ST88 (1) | t355 (4), t2526 (1) | 0(0) | 5 (100) |
*No vancomycin resistance was observed.N,n, sample size; MRSA, methicillin-resistant Staphylococcus aureus; PVL, Panton-Valentine leucocidin.